Breast Cancer Management Guidelines During COVID-19 Pandemic

被引：0
作者：
Kirti Katherine Manoj Gowda S
Sadaf Kabeer
Sekhar Jafferbhoy
Soni Marla
Vivek Soumian
Sankaran Misra
Adrian Murray Narayanan
机构：
[1] University Hospitals of North Midlands,Department of Breast Surgery
[2] The Christie NHS Foundation Trust,undefined
[3] Keele University,undefined
[4] Institute of Cancer Research,undefined
来源：
Indian Journal of Surgery | 2020年 / 82卷
关键词：
COVID-19; Breast cancer; Radiotherapy; Chemotherapy; Breast surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The coronavirus disease (COVID-19) pandemic in 2020 has brought about complex challenges in healthcare delivery. With the new rules of lockdown and social distancing and with resources diverted to the management of COVID-19, there are difficulties in continuing usual cancer care. Patients are at risk of contracting COVID-19 with a high chance of patient to healthcare transmission and vice versa. Hospital visits, investigations and all modalities of treatment have potential complications that put patients at risk, some more than others. In this situation, there is a need to change our approach in the management of breast cancer to deliver it safely. We present modified guidelines based on the available consensus statements and evidence.
引用
收藏
页码：251 / 258
页数：7
相关论文
共 42 条
  • [1] Liang W(2020)Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China Lancet Oncol 21 335-337
  • [2] Guan W(2015)A randomized, controlled trial of cavity shave margins in breast cancer N Engl J Med 373 503-510
  • [3] Chen R(1988)Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer BMJ 297 511-514
  • [4] Chagpar AB(2015)Update of the Phase III trial “GRETA” of surgery and tamoxifen versus tamoxifen alone for early breast cancer in elderly women Future Oncol Lond Engl 11 933-941
  • [5] Killelea BK(2016)Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis JAMA Oncol 2 1477-1486
  • [6] Tsangaris TN(2001)Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study Ann Oncol Off J Eur Soc Med Oncol 12 1527-1532
  • [7] Robertson JF(2005)Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial J Clin Oncol Off J Am Soc Clin Oncol 23 5108-5116
  • [8] Todd JH(2009)Increase in response rate by prolonged treatment with neoadjuvant letrozole Breast Cancer Res Treat 113 145-151
  • [9] Ellis IO(2017)Preoperative breast radiation therapy: Indications and perspectives Eur J Cancer Oxf Engl 1990 184-192
  • [10] Mustacchi G(2020)Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial Int J Radiat Oncol 106 958-967
12345